INSPIRE VETERINARY PARTNERS, INC. (IVPR)
As-reported financials and SEC filings for INSPIRE VETERINARY PARTNERS, INC. The latest annual period is FY2024. The latest reported quarter is Q3 FY2025. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
Note: this company’s most recent annual filing is more than a year old, so these figures may be out of date.
About INSPIRE VETERINARY PARTNERS, INC.
Inspire Veterinary Partners, Inc. operates veterinary services in the United States. The company provides veterinary care and related services primarily to pet owners. It serves clients through its network of veterinary facilities.
Snapshot
Fundamentals are from SEC filings for FY2024, the latest annual period (ended December 31, 2024). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.
Short interest
Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 2026-08-14 | 1.3M | -0.8% | 17.75 |
| 2026-07-31 | 1.3M | -0.0% | 1.00 |
| 2026-07-15 | 1.3M | -0.4% | 1.00 |
| 2026-06-30 | 1.3M | +1.8% | 1.00 |
| 2026-06-15 | 1.3M | -0.2% | 1.00 |
| 2026-05-29 | 1.3M | +0.9% | 1.00 |
| 2026-05-15 | 1.3M | -29.5% | 1.00 |
| 2026-04-30 | 1.9M | -6.1% | 1.00 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.
Income statement (as reported)
| FY2024 | FY2023 | FY2022 | |
|---|---|---|---|
| Revenue | $16.6M | $16.7M | $9.8M |
| Gross profit | — | — | — |
| Operating income | $-9.0M | $-7.2M | $-3.5M |
| Net income | $-14.3M | $-14.8M | $-4.9M |
| Diluted EPS | — | — | — |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Balance sheet (as reported)
| FY2024 | FY2023 | FY2022 | |
|---|---|---|---|
| Cash and equivalents | $523,690 | $178,961 | $444,253 |
| Current assets | $2.0M | $1.4M | $1.7M |
| Total assets | $20.2M | $21.8M | $20.2M |
| Current liabilities | $8.2M | $7.6M | $7.2M |
| Long-term debt | $12.0M | — | — |
| Total liabilities | $18.6M | $22.6M | $25.3M |
| Total equity | $1.6M | $-788,259 | $-5.1M |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Cash flow (as reported)
| FY2024 | FY2023 | FY2022 | |
|---|---|---|---|
| Operating cash flow | $-10.0M | $-3.8M | $-2.7M |
| Capital expenditure | $237,983 | $383,730 | $134,971 |
| Free cash flow | $-10.2M | $-4.2M | $-2.8M |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Quarterly trend (as reported)
| Quarter | Revenue | Revenue YoY | Net income | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2025 | $4.3M | 6.6% | $-2.5M | — |
| Q2 FY2025 | $4.3M | -2.4% | $-3.0M | — |
| Q1 FY2025 | $3.6M | -24.7% | $-2.4M | — |
| Q4 FY2024 | — | — | $-4.0M | — |
| Q3 FY2024 | $4.0M | -1.7% | $-3.5M | — |
| Q2 FY2024 | $4.4M | -2.2% | $-3.4M | — |
| Q1 FY2024 | $4.8M | 12.8% | $-3.4M | — |
| Q4 FY2023 | $3.8M | 19.0% | $-4.1M | — |
Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.
Company facts
Selected SEC filings
Largest Materials peers
Monitor IVPR
Get an alert when Inspire Veterinary Partners files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor IVPR freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.